{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["co-delivery", "meropenem", "mesoporous silica nanoparticles", "methicillin-resistant Staphylococcus aureus", "vancomycin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38002075", "DateRevised": {"Year": "2023", "Month": "11", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "16"}], "Language": ["eng"], "ELocationID": ["3075", "10.3390/biomedicines11113075"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "11", "Issue": "11", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "16"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Preparation, Physicochemical Characterization, Antimicrobial Effects, Biocompatibility and Cytotoxicity of Co-Loaded Meropenem and Vancomycin in Mesoporous Silica Nanoparticles.", "Abstract": {"AbstractText": ["Mesoporous silica nanoparticles (MSNPs) have been reported as an effective system to co-deliver a variety of different agents to enhance efficiency and improve biocompatibility. This study was aimed at the preparation, physicochemical characterization, antimicrobial effects, biocompatibility, and cytotoxicity of vancomycin and meropenem co-loaded in the mesoporous silica nanoparticles (Van/Mrp-MSNPs). The prepared nanoparticles were explored for their physicochemical features, antibacterial and antibiofilm effects, biocompatibility, and cytotoxicity. The minimum inhibitory concentrations (MICs) of the Van/Mrp-MSNPs (0.12-1 \u00b5g/mL) against <i>Staphylococcus aureus</i> isolates were observed to be lower than those of the same concentrations of vancomycin and meropenem. The minimum biofilm inhibitory concentration (MBIC) range of the Van/Mrp-MSNPs was 8-64 \u03bcg/mL, which was lower than the meropenem and vancomycin MBICs. The bacterial adherence was not significantly decreased upon exposure to levels lower than the MICs of the MSNPs and Van/Mrp-MSNPs. The viability of NIH/3T3 cells treated with serial concentrations of the MSNPs and Van/Mrp-MSNPs were 73-88% and 74-90%, respectively. The Van/Mrp-MSNPs displayed considerable inhibitory effects against MRSA, favorable biocompatibility, and low cytotoxicity. The Van/Mrp-MSNPs could be a potential system for the treatment of infections."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}, {"Identifier": [], "Affiliation": "Department of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan 87137-83976, Iran."}, {"Identifier": [], "Affiliation": "Student Research Committee, Kashan University of Medical Sciences, Kashan 87137-83976, Iran."}], "LastName": "Yekani", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Maragheh University of Medical Science, Maragheh 55158-78151, Iran."}], "LastName": "Azargun", "ForeName": "Robab", "Initials": "R"}, {"Identifier": ["0000-0002-3020-3779"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}], "LastName": "Sharifi", "ForeName": "Simin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}], "LastName": "Sadri Nahand", "ForeName": "Javid", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}, {"Identifier": [], "Affiliation": "Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}], "LastName": "Hasani", "ForeName": "Alka", "Initials": "A"}, {"Identifier": ["0000-0003-1580-3829"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}], "LastName": "Ghanbari", "ForeName": "Hadi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan 87137-83976, Iran."}], "LastName": "Sadat Seyyedi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}], "LastName": "Memar", "ForeName": "Mohammad Yousef", "Initials": "MY"}, {"Identifier": ["0000-0003-4759-7222"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 51548-53431, Iran."}], "LastName": "Maleki Dizaj", "ForeName": "Solmaz", "Initials": "S"}], "GrantList": [{"GrantID": "66760", "Agency": "Tabriz University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors reported no potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Horcajada J.P., Montero M., Oliver A., Sorl\u00ed L., Luque S., G\u00f3mez-Zorrilla S., Benito N., Grau S. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin. Microbiol. Rev. 2019;32:10\u2013128. doi: 10.1128/CMR.00031-19.", "ArticleIdList": ["10.1128/CMR.00031-19", "PMC6730496", "31462403"]}, {"Citation": "Rybak M.J. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin. Infect. Dis. 2006;42:S35\u2013S39. doi: 10.1086/491712.", "ArticleIdList": ["10.1086/491712", "16323118"]}, {"Citation": "Wu Q., Sabokroo N., Wang Y., Hashemian M., Karamollahi S., Kouhsari E. Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates. Antimicrob. Resist. Infect. Control. 2021;10:1\u20133. doi: 10.1186/s13756-021-00967-y.", "ArticleIdList": ["10.1186/s13756-021-00967-y", "PMC8247230", "34193295"]}, {"Citation": "Turner N.A., Sharma-Kuinkel B.K., Maskarinec S.A., Eichenberger E.M., Shah P.P., Carugati M., Holland T.L., Fowler V.G. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat. Rev. Microbiol. 2019;17:203\u2013218. doi: 10.1038/s41579-018-0147-4.", "ArticleIdList": ["10.1038/s41579-018-0147-4", "PMC6939889", "30737488"]}, {"Citation": "Totsuka K., Shiseki M., Kikuchi K., Matsui Y. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. J. Antimicrob. Chemother. 1999;44:455\u2013460. doi: 10.1093/jac/44.4.455.", "ArticleIdList": ["10.1093/jac/44.4.455", "10588305"]}, {"Citation": "Rochon-Edouard S., Pestel-Caron M., Lemeland J.-F., Caron F. In vitro synergistic effects of double and triple combinations of \u03b2-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 2000;44:3055\u20133060. doi: 10.1128/AAC.44.11.3055-3060.2000.", "ArticleIdList": ["10.1128/AAC.44.11.3055-3060.2000", "PMC101602", "11036022"]}, {"Citation": "Mohammadi-Berenjestanaki H., Khori V., Shirzad-Aski H., Ghaemi E.A. In vitro synergistic effect of vancomycin and some antibacterial agents against clinical methicillin-resistant and sensitive Staphylococcus aureus isolates. Microb. Drug Resist. 2020;26:218\u2013226. doi: 10.1089/mdr.2019.0003.", "ArticleIdList": ["10.1089/mdr.2019.0003", "31424323"]}, {"Citation": "Wicha S.G., Kees M.G., Kuss J., Kloft C. Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureus. Pharm. Res. 2015;32:2410\u20132418. doi: 10.1007/s11095-015-1632-3.", "ArticleIdList": ["10.1007/s11095-015-1632-3", "25630818"]}, {"Citation": "Yetisgin A.A., Cetinel S., Zuvin M., Kosar A., Kutlu O.J.M. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25:2193. doi: 10.3390/molecules25092193.", "ArticleIdList": ["10.3390/molecules25092193", "PMC7248934", "32397080"]}, {"Citation": "Maleki Dizaj S., Sharifi S., Jahangiri A. Electrospun nanofibers as versatile platform in antimicrobial delivery: Current state and perspectives. Pharm. Dev. Technol. 2019;24:1187\u20131199. doi: 10.1080/10837450.2019.1656238.", "ArticleIdList": ["10.1080/10837450.2019.1656238", "31424308"]}, {"Citation": "Ahmed H., Gomte S.S., Prathyusha E., Prabakaran A., Agrawal M., Alexander A. Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier. J. Drug Deliv. Sci. Technol. 2022;76:103729. doi: 10.1016/j.jddst.2022.103729.", "ArticleIdList": ["10.1016/j.jddst.2022.103729"]}, {"Citation": "Zhuang J., Yu Y., Lu R. Mesoporous silica nanoparticles as carrier to overcome bacterial drug resistant barriers. Int. J. Pharm. 2022;631:122529. doi: 10.1016/j.ijpharm.2022.122529.", "ArticleIdList": ["10.1016/j.ijpharm.2022.122529", "36563796"]}, {"Citation": "Paris J.L., Vallet-Reg\u00ed M. Mesoporous silica nanoparticles for co-delivery of drugs and nucleic acids in oncology: A review. Pharmaceutics. 2020;12:526. doi: 10.3390/pharmaceutics12060526.", "ArticleIdList": ["10.3390/pharmaceutics12060526", "PMC7356816", "32521800"]}, {"Citation": "Memar M.Y., Yekani M., Ghanbari H., Shahi S., Sharifi S., Maleki Dizaj S. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Enterobacteriaceae. Artif. Cells Nanomed. Biotechnol. 2020;48:1354\u20131361. doi: 10.1080/21691401.2020.1850466.", "ArticleIdList": ["10.1080/21691401.2020.1850466", "33236938"]}, {"Citation": "Memar M.Y., Yekani M., Ghanbari H., Nabizadeh E., Vahed S.Z., Dizaj S.M., Sharifi S. Antimicrobial and antibiofilm activities of meropenem loaded-mesoporous silica nanoparticles against carbapenem-resistant Pseudomonas aeruginosa. J. Biomater. Appl. 2021;36:605\u2013612. doi: 10.1177/08853282211003848.", "ArticleIdList": ["10.1177/08853282211003848", "33722086"]}, {"Citation": "Memar M.Y., Yekani M., Farajnia S., Ghadiri Moghaddam F., Nabizadeh E., Sharifi S., Maleki Dizaj S. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria. Arch. Microbiol. 2023;205:109. doi: 10.1007/s00203-023-03447-6.", "ArticleIdList": ["10.1007/s00203-023-03447-6", "36884153"]}, {"Citation": "Hanafi-Bojd M.Y., Ansari L., Mosaffa F., Malaekeh-Nikouei B. The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells. Nanomed. J. 2017;4:135\u2013141."}, {"Citation": "Maleki Dizaj S., Lotfipour F., Barzegar-Jalali M., Zarrintan M.-H., Adibkia K. Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: Preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus. Artif. Cells Nanomed. Biotechnol. 2017;45:535\u2013543. doi: 10.3109/21691401.2016.1161637.", "ArticleIdList": ["10.3109/21691401.2016.1161637", "27012878"]}, {"Citation": "Tille P. Bailey & Scott\u2019s Diagnostic Microbiology-E-Book. Elsevier Health Sciences; Amsterdam, The Netherlands: 2015."}, {"Citation": "In C. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2018."}, {"Citation": "Sopirala M.M., Mangino J.E., Gebreyes W.A., Biller B., Bannerman T., Balada-Llasat J.M., Preeti Pancholi P. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2010;54:4678\u20134683. doi: 10.1128/AAC.00497-10.", "ArticleIdList": ["10.1128/AAC.00497-10", "PMC2976112", "20713678"]}, {"Citation": "Weinstein M.P. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. National Committee for Clinical Laboratory Standards; Wayne, PA, USA: 2018."}, {"Citation": "Hayat S., Muzammil S., Rasool M.H., Nisar Z., Hussain S.Z., Sabri A.N., Jamil S. In vitro antibiofilm and anti-adhesion effects of magnesium oxide nanoparticles against antibiotic resistant bacteria. Microbiol. Immunol. 2018;62:211\u2013220. doi: 10.1111/1348-0421.12580.", "ArticleIdList": ["10.1111/1348-0421.12580", "29405384"]}, {"Citation": "Rahimi M., Safa K.D., Salehi R. Co-delivery of doxorubicin and methotrexate by dendritic chi-tosan-g-mPEG as a magnetic nanocarrier for multi-drug delivery in combination chemotherapy. Polym. Chem. 2017;8:7333\u20137350. doi: 10.1039/C7PY01701D.", "ArticleIdList": ["10.1039/C7PY01701D"]}, {"Citation": "Achilli C., Grandi S., Ciana A., Guidetti G.F., Malara A., Abbonante V., Cansolino L., Tomasi C., Balduini A., Fagnoni M. Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application. Nanomed. Nanotechnol. Biol. Med. 2014;10:589\u2013597. doi: 10.1016/j.nano.2013.10.003.", "ArticleIdList": ["10.1016/j.nano.2013.10.003", "24161383"]}, {"Citation": "Xu P., Yao J., Li Z., Wang M., Zhou L., Zhong G., Zheng Y., Li N., Zhai Z., Yang S. Therapeutic effect of doxorubicin-chlorin E6-loaded mesoporous silica nanoparticles combined with ultrasound on triple-negative breast cancer. Int. J. Nanomed. 2020;15:2659\u20132668. doi: 10.2147/IJN.S243037.", "ArticleIdList": ["10.2147/IJN.S243037", "PMC7183747", "32368047"]}, {"Citation": "Gounani Z., Asadollahi M.A., Meyer R.L., Arpanaei A. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility. Int. J. Pharm. 2018;537:148\u2013161. doi: 10.1016/j.ijpharm.2017.12.039.", "ArticleIdList": ["10.1016/j.ijpharm.2017.12.039", "29278732"]}, {"Citation": "Koneru B., Shi Y., Wang Y.-C., Chavala S.H., Miller M.L., Holbert B., Conson M., Ni A., Di Pasqua A.J. Tetracycline-containing MCM-41 mesoporous silica nanoparticles for the treatment of Escherichia coli. Molecules. 2015;20:19690\u201319698. doi: 10.3390/molecules201119650.", "ArticleIdList": ["10.3390/molecules201119650", "PMC6332305", "26528964"]}, {"Citation": "Colilla M., Vallet-Reg\u00ed M. Targeted stimuli-responsive mesoporous silica nanoparticles for bacterial infection treatment. Int. J. Mol. Sci. 2020;21:8605. doi: 10.3390/ijms21228605.", "ArticleIdList": ["10.3390/ijms21228605", "PMC7696808", "33203098"]}, {"Citation": "R\u0103dulescu D., Voicu G., Oprea A.E., Andronescu E., Grumezescu V., Holban A.M., Vasile B.S., Surdu A.V., Grumezescu A.M., Socol G. Mesoporous silica coatings for cephalosporin active release at the bone-implant interface. Appl. Surf. Sci. 2016;374:165\u2013171. doi: 10.1016/j.apsusc.2015.10.183.", "ArticleIdList": ["10.1016/j.apsusc.2015.10.183"]}, {"Citation": "Chen Y., Chen H., Zhang S., Chen F., Zhang L., Zhang J., Zhu M., Wu H., Guo L., Feng J. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv. Funct. Mater. 2011;21:270\u2013278. doi: 10.1002/adfm.201001495.", "ArticleIdList": ["10.1002/adfm.201001495"]}, {"Citation": "He Q., Zhang J., Shi J., Zhu Z., Zhang L., Bu W., Guo L., Chen Y. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials. 2010;31:1085\u20131092. doi: 10.1016/j.biomaterials.2009.10.046.", "ArticleIdList": ["10.1016/j.biomaterials.2009.10.046", "19880176"]}, {"Citation": "Xi G., Liu W., Chen M., Li Q., Hao X., Wang M., Yang X., Feng Y., He H., Shi C. Polysaccharide-based lotus seedpod surface-like porous microsphere with precise and controllable micromorphology for ultrarapid hemostasis. ACS Appl. Mater. Interfaces. 2019;11:46558\u201346571. doi: 10.1021/acsami.9b17543.", "ArticleIdList": ["10.1021/acsami.9b17543", "31769962"]}, {"Citation": "Gessner A., Lieske A., Paulke B.R., M\u00fcller R.H. Functional groups on polystyrene model nanoparticles: Influence on protein adsorption. J. Biomed. Mater. Res. Part A. 2003;65:319\u2013326. doi: 10.1002/jbm.a.10371.", "ArticleIdList": ["10.1002/jbm.a.10371", "12746878"]}, {"Citation": "Cristian R.E., Mohammad I.J., Mernea M., Sbarcea B.G., Trica B., Stan M.S., Dinischiotu A. Analyzing the interaction between two different types of nanoparticles and serum albumin. Materials. 2019;12:3183. doi: 10.3390/ma12193183.", "ArticleIdList": ["10.3390/ma12193183", "PMC6804176", "31569341"]}, {"Citation": "Shegokar R., Al Shaal L., Mitri K. Present status of nanoparticle research for treatment of tuberculosis. J. Pharm. Pharm. Sci. 2011;14:100\u2013116. doi: 10.18433/J3M59P.", "ArticleIdList": ["10.18433/J3M59P", "21501557"]}, {"Citation": "Biological Evaluation of Medical Devices\u2014Part 5: Tests For In Vitro Cytotoxicity. International. International Organization for Standardization; Geneve, Switzerland: 2009."}, {"Citation": "Murashov V., Harper M., Demchuk E. Impact of silanol surface density on the toxicity of silica aerosols measured by erythrocyte haemolysis. J. Occup. Environ. Hyg. 2006;3:718\u2013723. doi: 10.1080/15459620601015950.", "ArticleIdList": ["10.1080/15459620601015950", "17133693"]}, {"Citation": "Son Y.-H., Choy Y.B., Choi H.R., Kim D.S., Park K.C., Choy J.-H. One-pot synthetic route to polymer\u2013silica assembled capsule encased with nonionic drug molecule. Chem. Commun. 2007;27:2799\u20132801. doi: 10.1039/B702288C.", "ArticleIdList": ["10.1039/B702288C", "17609780"]}, {"Citation": "Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small. 2007;3:1341\u20131346. doi: 10.1002/smll.200700005.", "ArticleIdList": ["10.1002/smll.200700005", "17566138"]}, {"Citation": "Menon N., Leong D.T. Cytotoxic effects of phosphonate-functionalized mesoporous silica nanoparticles. ACS Appl. Mater. Interfaces. 2016;8:2416\u20132422. doi: 10.1021/acsami.5b11741.", "ArticleIdList": ["10.1021/acsami.5b11741", "26741564"]}, {"Citation": "Slowing I.I., Wu C.W., Vivero-Escoto J.L., Lin V.S.Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small. 2009;5:57\u201362. doi: 10.1002/smll.200800926.", "ArticleIdList": ["10.1002/smll.200800926", "19051185"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "17"}, {"Year": "2023", "Month": "11", "Day": "5"}, {"Year": "2023", "Month": "11", "Day": "9"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "46"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "1", "Minute": "8"}, {"Year": "2023", "Month": "11", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["38002075", "PMC10669092", "10.3390/biomedicines11113075", "biomedicines11113075"]}}], "PubmedBookArticle": []}